How does oxidative stress during pregnancy influence the child’s behavior and emotional states?

PHILADEL­PHIA — Ever since Ei­sai first re­vealed da­ta from its piv­otal Alzheimer’s dis­ease study two years ago, the com­pa­ny has ar­gued that treat­ing pa­tients with

The FDA has approved the first biosimilar version of the interleukin-6 (IL-6) blocker tocilizumab, to be marketed as Tofidence and with indications for rheumatoid arthritis